[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pneumococcal-disease-invasive\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pneumococcal-disease-invasive":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100608725",false,"NCT07205289","Serum Collection Study for Assay Development","A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation","Inclusion Criteria:\n\n* good general health\n\nExclusion Criteria:\n\n* no previous pneumococcal vaccine",true,"ALL","18 Years","69 Years",{"count":20,"type":21},12,"ESTIMATED","INTERVENTIONAL",[24],"PHASE1","The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation",[27,28],"Pneumococcal Disease, Invasive","Pneumococcal Disease",[30],"Vaccination pneumococcal","RECRUITING","2025-09-25",{"date":34,"type":35},"2025-10-03","ACTUAL",{"date":37,"type":21},"2025-10",{"date":39,"type":21},"2026-06",{"name":41,"class":42},"GPN Vaccines","INDUSTRY",""]